Transplantation of Mesenchymal Stem Cells Exerts a Greater Long-Term Effect than Bone Marrow Mononuclear Cells in a Chronic Myocardial Infarction Model in Rat - Manuel Mazo, Juan José Gavira, Gloria Abizanda, Cristina
Muscle | SpringerLink
å¦ æœ¯ 论 æ–‡ 集
Published Research Articles - Desmoid Tumor Research Foundation
Resident cardiac progenitor cells: At the heart of regeneration - Journal of Molecular and Cellular Cardiology
PDF) A Phase II Study of Autologous Mesenchymal Stromal Cells and c‐kit Positive Cardiac Cells, Alone or in Combination, in Patients with Ischemic Heart Failure: The CCTRN CONCERT‐HF Trial
PDF) Management of Chronic Congestive Heart Failure Caused by Myxomatous Mitral Valve Disease in Dogs: A Narrative Review from 1970 to 2020
A Phase II study of autologous mesenchymal stromal cells and c‐kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT‐HF trial - Bolli - 2021 -
Factors Affecting Residence Time of Mesenchymal Stromal Cells (MSC) Injected into the Myocardium - Jason Westrich, Peter Yaeger, Chufa He, Jeff Stewart, Raymond Chen, Gitta Seleznik, Shane Larson, Bruce Wentworth, Michael O'callaghan,
PDF) Cell therapy in myocardial infarction: Emphasis on the role of MRI
Factors associated with implantable cardioverter defibrillators appropriate therapy in cardiac sarcoidosis: a meta-analysis
Calaméo - Eleftheria.gr_18/12/2009
PDF) Multi-Omics Approach Profiling Metabolic Remodeling in Early Systolic Dysfunction and in Overt Systolic Heart Failure
Diabetic Mesenchymal Stem Cells Are Ineffective for Improving Limb Ischemia Due to Their Impaired Angiogenic Capability - Hyongbum Kim, Ji Woong Han, Ji Yoon Lee, Yong Jin Choi, Young-Doug Sohn, Myungjae Song,